Safety of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke
Public ClinicalTrials.gov record NCT00075959. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
CHANT (Cerebral Hemorrhage And NXY Treatment) A Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multicenter, Phase IIb Study to Assess the Safety and Tolerability of Intravenous Infusion of NXY-059 in Adult Patients With Acute Intracerebral Hemorrhage (ICH)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will determine if NXY-059 is safe in patients with an acute stroke caused by bleeding in the central nervous system. The primary objective was to assess the safety and tolerability of NXY-059 compared to placebo.
Study identification
- NCT ID
- NCT00075959
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 600 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2004 (Type not available)
- Primary completion
- Jan 2006 (Actual)
- Completion
- Jan 2006 (Actual)
- Last update posted
- Jan 4, 2013
2004 – 2006
United States locations
- U.S. sites
- 64
- U.S. states
- 30
- U.S. cities
- 64
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Birmingham | Alabama | — | — |
| Research Site | Scottsdale | Arizona | — | — |
| Research Site | Fort Smith | Arkansas | — | — |
| Research Site | Carmichael | California | — | — |
| Research Site | Sacramento | California | — | — |
| Research Site | San Diego | California | — | — |
| Research Site | San Jose | California | — | — |
| Research Site | Santa Rosa | California | — | — |
| Research Site | Walnut Creek | California | — | — |
| Research Site | Danbury | Connecticut | — | — |
| Research Site | Melbourne | Florida | — | — |
| Research Site | Ocala | Florida | — | — |
| Research Site | Pompano Beach | Florida | — | — |
| Research Site | Port Charlotte | Florida | — | — |
| Research Site | Punta Gorda | Florida | — | — |
| Research Site | Tampa | Florida | — | — |
| Research Site | Weston | Florida | — | — |
| Research Site | Atlanta | Georgia | — | — |
| Research Site | Decatur | Georgia | — | — |
| Research Site | Duluth | Georgia | — | — |
| Research Site | Lawrenceville | Georgia | — | — |
| Research Site | Honolulu | Hawaii | — | — |
| Research Site | Arlington Heights | Illinois | — | — |
| Research Site | Maywood | Illinois | — | — |
| Research Site | Fort Wayne | Indiana | — | — |
| Research Site | Des Moines | Iowa | — | — |
| Research Site | Louisville | Kentucky | — | — |
| Research Site | Marrero | Louisiana | — | — |
| Research Site | Shreveport | Louisiana | — | — |
| Research Site | South Weymouth | Massachusetts | — | — |
| Research Site | Worcester | Massachusetts | — | — |
| Research Site | Ann Arbor | Michigan | — | — |
| Research Site | East Lansing | Michigan | — | — |
| Research Site | Robbinsdale | Minnesota | — | — |
| Research Site | Kansas City | Missouri | — | — |
| Research Site | Omaha | Nebraska | — | — |
| Research Site | Reno | Nevada | — | — |
| Research Site | Edison | New Jersey | — | — |
| Research Site | Holmdel | New Jersey | — | — |
| Research Site | Morristown | New Jersey | — | — |
| Research Site | Ridgewood | New Jersey | — | — |
| Research Site | Summit | New Jersey | — | — |
| Research Site | Manhasset | New York | — | — |
| Research Site | Schenectady | New York | — | — |
| Research Site | Durham | North Carolina | — | — |
| Research Site | Winston-Salem | North Carolina | — | — |
| Research Site | Akron | Ohio | — | — |
| Research Site | Cleveland | Ohio | — | — |
| Research Site | Toledo | Ohio | — | — |
| Research Site | Youngstown | Ohio | — | — |
| Research Site | Oklahoma City | Oklahoma | — | — |
| Research Site | Abington | Pennsylvania | — | — |
| Research Site | Danville | Pennsylvania | — | — |
| Research Site | Hershey | Pennsylvania | — | — |
| Research Site | Philadelphia | Pennsylvania | — | — |
| Research Site | Pittsburgh | Pennsylvania | — | — |
| Research Site | Bristol | Tennessee | — | — |
| Research Site | Memphis | Tennessee | — | — |
| Research Site | Houston | Texas | — | — |
| Research Site | Lubbock | Texas | — | — |
| Research Site | Virginia Beach | Virginia | — | — |
| Research Site | Olympia | Washington | — | — |
| Research Site | Madison | Wisconsin | — | — |
| Research Site | Marshfield | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00075959, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 4, 2013 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00075959 live on ClinicalTrials.gov.